191 related articles for article (PubMed ID: 26427665)
1. The emerging role of Nemo-like kinase (NLK) in the regulation of cancers.
Huang Y; Yang Y; He Y; Li J
Tumour Biol; 2015 Dec; 36(12):9147-52. PubMed ID: 26427665
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of Nemo-like kinase expression in patients with hepatocellular carcinoma.
Chen HW; Qiao HY; Li HC; Li ZF; Zhang HJ; Pei L; Liu HW; Jin L; Wang D; Li JL
Tumour Biol; 2015 Nov; 36(11):8447-53. PubMed ID: 26022162
[TBL] [Abstract][Full Text] [Related]
3. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
[TBL] [Abstract][Full Text] [Related]
4. Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer.
Wang J; Yang ZH; Chen H; Li HH; Chen LY; Zhu Z; Zou Y; Ding CC; Yang J; He ZW
BMC Cancer; 2016 Mar; 16():257. PubMed ID: 27036119
[TBL] [Abstract][Full Text] [Related]
5. Lentivirus-mediated knockdown of NLK inhibits small-cell lung cancer growth and metastasis.
Lv M; Li Y; Tian X; Dai S; Sun J; Jin G; Jiang S
Drug Des Devel Ther; 2016; 10():3737-3746. PubMed ID: 27895463
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor Prognosis.
Lei L; Wang Y; Zheng YW; Fei LR; Shen HY; Li ZH; Huang WJ; Yu JH; Xu HT
Curr Cancer Drug Targets; 2019; 19(8):674-680. PubMed ID: 30451112
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biological significance of nemo-like kinase expression in glioma.
Cui G; Li Z; Shao B; Zhao L; Zhou Y; Lu T; Wang J; Shi X; Wang J; Zuo G; Zhu W; Shen A
J Clin Neurosci; 2011 Feb; 18(2):271-5. PubMed ID: 21177110
[TBL] [Abstract][Full Text] [Related]
9. Expression of Nemo-like kinase was increased and negatively correlated with the expression of TCF4 in lung cancers.
Zhang XW; Chen SY; Xue DW; Xu HH; Yang LH; Xu HT; Wang EH
Int J Clin Exp Pathol; 2015; 8(11):15086-92. PubMed ID: 26823848
[TBL] [Abstract][Full Text] [Related]
10. Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells.
Emami KH; Brown LG; Pitts TE; Sun X; Vessella RL; Corey E
Prostate; 2009 Oct; 69(14):1481-92. PubMed ID: 19514049
[TBL] [Abstract][Full Text] [Related]
11. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
[TBL] [Abstract][Full Text] [Related]
12. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer.
Han Y; Kuang Y; Xue X; Guo X; Li P; Wang X; Guo X; Yuan B; Zhi Q; Zhao H
Biomed Pharmacother; 2014 Jun; 68(5):497-505. PubMed ID: 24972723
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-92b promotes tumor growth and activation of NF-κB signaling via regulation of NLK in oral squamous cell carcinoma.
Liu Z; Diep C; Mao T; Huang L; Merrill R; Zhang Z; Peng Y
Oncol Rep; 2015 Dec; 34(6):2961-8. PubMed ID: 26503628
[TBL] [Abstract][Full Text] [Related]
14. Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells.
Yasuda J; Tsuchiya A; Yamada T; Sakamoto M; Sekiya T; Hirohashi S
Biochem Biophys Res Commun; 2003 Aug; 308(2):227-33. PubMed ID: 12901858
[TBL] [Abstract][Full Text] [Related]
15. Lentivirus‑delivered nemo‑like kinase small interfering RNA inhibits laryngeal cancer cell proliferation in vitro.
Tai J; Rao Y; Fang J; Huang Z; Yu Z; Chen X; Zhou W; Xiao X; Long T; Han Y; Liu Q; Li A; Ni X
Mol Med Rep; 2015 Oct; 12(4):5619-24. PubMed ID: 26252054
[TBL] [Abstract][Full Text] [Related]
16. Lentivirus-based RNA silencing of Nemo-like kinase (NLK) inhibits the CAL 27 human adenosquamos carcinoma cells proliferation and blocks G0/G1 phase to S phase.
Zhang B; Li KY; Chen HY; Pan SD; Chen SF; Zhang WF; Xia CP; Jiang LC; Liu XB; Zhao FJ; Yuan DY; Wang le X; Wu YP; Liu SW
Int J Med Sci; 2013; 10(10):1301-6. PubMed ID: 23983589
[TBL] [Abstract][Full Text] [Related]
17. Nemo-like kinase is involved in NGF-induced neurite outgrowth via phosphorylating MAP1B and paxillin.
Ishitani T; Ishitani S; Matsumoto K; Itoh M
J Neurochem; 2009 Dec; 111(5):1104-18. PubMed ID: 19840224
[TBL] [Abstract][Full Text] [Related]
18. MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK.
Zou D; Wang D; Li R; Tang Y; Yuan L; Long X; Zhou Q
Tumour Biol; 2015 Sep; 36(9):6725-32. PubMed ID: 25833695
[TBL] [Abstract][Full Text] [Related]
19. miR-362-3p targets nemo-like kinase and functions as a tumor suppressor in renal cancer cells.
Zou X; Zhong J; Li J; Su Z; Chen Y; Deng W; Li Y; Lu S; Lin Y; Luo L; Li Z; Cai Z; Tang A
Mol Med Rep; 2016 Jan; 13(1):994-1002. PubMed ID: 26647877
[TBL] [Abstract][Full Text] [Related]
20. In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma.
Sa JK; Yoon Y; Kim M; Kim Y; Cho HJ; Lee JK; Kim GS; Han S; Kim WJ; Shin YJ; Joo KM; Paddison PJ; Ishitani T; Lee J; Nam DH
Oncotarget; 2015 Aug; 6(24):20145-59. PubMed ID: 26023737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
